Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03229265Phase 4Completed
A Phase 4 trial of patiromer in hyperkalemia, sponsored by Rogosin Institute. Started Aug 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03229265.